Moderna: Momentum Bull Rises to a Multi-Year High - The Outlined Trend Following Scenario has its Effect!

About Moderna (MRNA) , I last reported on this on September 17. Since then, the stock has risen from $160 to $224. This represents a price increase of 40% in less than a month. At the same time, the stock managed to break out to a multi-year high and build an outstanding "medium-term trend strength" of currently 11.1%. For speculative trend followers who can handle the increased volatility of the underlying asset, these are very positive conditions. In addition to the convincing price behavior, I find the story particularly exciting. The company...